Login

Brickworks Ltd MD Discusses Full Year Results, Property Trust, and Dividend Policy with Tom Piotrowski | Lindsay Partridge - CEO of brickworks ltd 00:10:00

Share On Facebook Share On Twitter

Lindsay Partridge is the CEO of brickworks ltd

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Metallic Minerals: Advancing High-Grade Silver Projects in the Yukon
00:10:00
Brink’s CEO: Conditions for U.S. Marijuana Dispensary Partnership & Industry Opportunities | Douglas A Pertz - CEO of Brink's
00:10:00
Interview with Davidski, General Manager of the Bitcoin Investment Trust, on Institutional Bitcoin Access and Trading.
00:00:00
Andrew Kruse, Ph.D. Professor of Biological Chemistry and Molecular Pharmacology, HMS| Molecular Activity Behind Human Physiology and Disease
00:10:00
"Unveiling Excellence: The Strategic Vision and Expertise of Permal - A Legg Mason Company"
00:10:00
John Zito, portfolio manager for credit opportunities at Brencourt Advisors LLC, discusses his investment strategy focusing on credit opportunities.
00:10:00
Exploring New Frontiers: Canex Metals' Promising Gold Discoveries in Northern Arizona
00:10:00
invest in mission driven founders|Satya Patel,Partner,Homebrew
00:10:00
Enhancing Strategic Thought: Analytical and Creative Thinking Training by Kasikorn Asset Management | D4 Consultant - Professional Development Experts
00:10:00
Gravity Doesn't Apply Here: New Orbits for Venture Capital|Salil Deshpande,Investor, Uncorrelated
00:10:00
Top 5 Criteria for Choosing a Record Keeper
00:10:00
Ari Kahn and John Murcott Explore AI's Impact on Search and Merchandising | Ari Kahn, CEO , Bridgeline Digital Inc.

© 2017 - Neuhu+